Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene

Toshiaki Saeki, Audrey Cristiano, Mark J. Lynch, Michael Brattain, Nancy Kim, Nicola Normanno, Nicholas Kenney, Fortunato Ciardiello, David S. Salomon

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Expression of transforming growth factor α (TGFα) mRNA and protein can be stimulated by estrogens such as 17β-estradiol (E2) in estrogen-responsive rodent and human breast cancer cells. To ascertain if E2 can directly regulate TGFα expression through the 5′-flanking region of the human TGFα gene, E2- responsive MCF-7 or ZR-75-1 human breast cancer cells or E2-nonresponsive MDA-MB-231 breast cancer cells were transiently transfected with a plasmid containing an 1140-base pair (bp) Sac-I fragment of the TGFα 5′-flanking region ligated to the chloramphenicol acetyltransferase (CAT) gene. Cells that were transfected and subsequently treated with physiological concentrations of E2 (10−11-10−8 M) for 24 h exhibited a 2- to 10-fold increase in CAT activity. The E2 stimulation of CAT activity was dose-dependent with an increase first found at 10−10 M E2. The increase in CAT activity could be detected within 24-36 h after the addition of E2. There was no significant change in CAT activity in transiently transfected MDA-MB-231 cells as mediated through the TGFα 5′-flanking region after E2 treatment. MCF- 7 cells were also transiently transfected with different fragments of the TGFα 5′-flanking region ligated to the luciferase gene. In the absence of E2 treatment, no detectable luciferase activity was found. E2 was able to stimulate, in a dose-dependent manner, a 30- to 300-fold increase in luciferase activity in MCF-7 cells, which have been transfected with either a 2813-bp Pst-I, a 1565-bp Spe-I, a 1140-bp Sac-I, or a 370-bp Bam-HI TGFα-luciferase fragment. However, a loss in E2 responsiveness occurred when MCF-7 cells were transfected with a 77-bp Sac-II TGFα-luciferase plasmid. The induction of luciferase activity by E2 could be effectively blocked by simultaneous treatment of the cells with the antiestrogens tamoxifen or droloxifene. In addition, the increase in luciferase activity was specific for E2 since progesterone or dexamethasone were ineffective in modifying luciferase activity through the TGFα 5′-flanking sequence. The results show that the TGFα 5′-flanking region contains a potential estrogen-responsive element(s) and that this region is upstream of the Sac-II restriction site.

Original languageEnglish (US)
Pages (from-to)1955-1963
Number of pages9
JournalMolecular Endocrinology
Volume5
Issue number12
DOIs
StatePublished - Dec 1991

Fingerprint

5' Flanking Region
Transforming Growth Factors
Estrogens
Luciferases
Chloramphenicol O-Acetyltransferase
Base Pairing
Genes
MCF-7 Cells
Breast Neoplasms
Plasmids
Estrogen Receptor Modulators
Tamoxifen
Dexamethasone
Progesterone
Estradiol
Rodentia
Messenger RNA

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Saeki, T., Cristiano, A., Lynch, M. J., Brattain, M., Kim, N., Normanno, N., ... Salomon, D. S. (1991). Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene. Molecular Endocrinology, 5(12), 1955-1963. https://doi.org/10.1210/mend-5-12-1955

Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene. / Saeki, Toshiaki; Cristiano, Audrey; Lynch, Mark J.; Brattain, Michael; Kim, Nancy; Normanno, Nicola; Kenney, Nicholas; Ciardiello, Fortunato; Salomon, David S.

In: Molecular Endocrinology, Vol. 5, No. 12, 12.1991, p. 1955-1963.

Research output: Contribution to journalArticle

Saeki, T, Cristiano, A, Lynch, MJ, Brattain, M, Kim, N, Normanno, N, Kenney, N, Ciardiello, F & Salomon, DS 1991, 'Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene', Molecular Endocrinology, vol. 5, no. 12, pp. 1955-1963. https://doi.org/10.1210/mend-5-12-1955
Saeki, Toshiaki ; Cristiano, Audrey ; Lynch, Mark J. ; Brattain, Michael ; Kim, Nancy ; Normanno, Nicola ; Kenney, Nicholas ; Ciardiello, Fortunato ; Salomon, David S. / Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene. In: Molecular Endocrinology. 1991 ; Vol. 5, No. 12. pp. 1955-1963.
@article{567847bf2afc43ccba5ca4b77097f9da,
title = "Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene",
abstract = "Expression of transforming growth factor α (TGFα) mRNA and protein can be stimulated by estrogens such as 17β-estradiol (E2) in estrogen-responsive rodent and human breast cancer cells. To ascertain if E2 can directly regulate TGFα expression through the 5′-flanking region of the human TGFα gene, E2- responsive MCF-7 or ZR-75-1 human breast cancer cells or E2-nonresponsive MDA-MB-231 breast cancer cells were transiently transfected with a plasmid containing an 1140-base pair (bp) Sac-I fragment of the TGFα 5′-flanking region ligated to the chloramphenicol acetyltransferase (CAT) gene. Cells that were transfected and subsequently treated with physiological concentrations of E2 (10−11-10−8 M) for 24 h exhibited a 2- to 10-fold increase in CAT activity. The E2 stimulation of CAT activity was dose-dependent with an increase first found at 10−10 M E2. The increase in CAT activity could be detected within 24-36 h after the addition of E2. There was no significant change in CAT activity in transiently transfected MDA-MB-231 cells as mediated through the TGFα 5′-flanking region after E2 treatment. MCF- 7 cells were also transiently transfected with different fragments of the TGFα 5′-flanking region ligated to the luciferase gene. In the absence of E2 treatment, no detectable luciferase activity was found. E2 was able to stimulate, in a dose-dependent manner, a 30- to 300-fold increase in luciferase activity in MCF-7 cells, which have been transfected with either a 2813-bp Pst-I, a 1565-bp Spe-I, a 1140-bp Sac-I, or a 370-bp Bam-HI TGFα-luciferase fragment. However, a loss in E2 responsiveness occurred when MCF-7 cells were transfected with a 77-bp Sac-II TGFα-luciferase plasmid. The induction of luciferase activity by E2 could be effectively blocked by simultaneous treatment of the cells with the antiestrogens tamoxifen or droloxifene. In addition, the increase in luciferase activity was specific for E2 since progesterone or dexamethasone were ineffective in modifying luciferase activity through the TGFα 5′-flanking sequence. The results show that the TGFα 5′-flanking region contains a potential estrogen-responsive element(s) and that this region is upstream of the Sac-II restriction site.",
author = "Toshiaki Saeki and Audrey Cristiano and Lynch, {Mark J.} and Michael Brattain and Nancy Kim and Nicola Normanno and Nicholas Kenney and Fortunato Ciardiello and Salomon, {David S.}",
year = "1991",
month = "12",
doi = "10.1210/mend-5-12-1955",
language = "English (US)",
volume = "5",
pages = "1955--1963",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene

AU - Saeki, Toshiaki

AU - Cristiano, Audrey

AU - Lynch, Mark J.

AU - Brattain, Michael

AU - Kim, Nancy

AU - Normanno, Nicola

AU - Kenney, Nicholas

AU - Ciardiello, Fortunato

AU - Salomon, David S.

PY - 1991/12

Y1 - 1991/12

N2 - Expression of transforming growth factor α (TGFα) mRNA and protein can be stimulated by estrogens such as 17β-estradiol (E2) in estrogen-responsive rodent and human breast cancer cells. To ascertain if E2 can directly regulate TGFα expression through the 5′-flanking region of the human TGFα gene, E2- responsive MCF-7 or ZR-75-1 human breast cancer cells or E2-nonresponsive MDA-MB-231 breast cancer cells were transiently transfected with a plasmid containing an 1140-base pair (bp) Sac-I fragment of the TGFα 5′-flanking region ligated to the chloramphenicol acetyltransferase (CAT) gene. Cells that were transfected and subsequently treated with physiological concentrations of E2 (10−11-10−8 M) for 24 h exhibited a 2- to 10-fold increase in CAT activity. The E2 stimulation of CAT activity was dose-dependent with an increase first found at 10−10 M E2. The increase in CAT activity could be detected within 24-36 h after the addition of E2. There was no significant change in CAT activity in transiently transfected MDA-MB-231 cells as mediated through the TGFα 5′-flanking region after E2 treatment. MCF- 7 cells were also transiently transfected with different fragments of the TGFα 5′-flanking region ligated to the luciferase gene. In the absence of E2 treatment, no detectable luciferase activity was found. E2 was able to stimulate, in a dose-dependent manner, a 30- to 300-fold increase in luciferase activity in MCF-7 cells, which have been transfected with either a 2813-bp Pst-I, a 1565-bp Spe-I, a 1140-bp Sac-I, or a 370-bp Bam-HI TGFα-luciferase fragment. However, a loss in E2 responsiveness occurred when MCF-7 cells were transfected with a 77-bp Sac-II TGFα-luciferase plasmid. The induction of luciferase activity by E2 could be effectively blocked by simultaneous treatment of the cells with the antiestrogens tamoxifen or droloxifene. In addition, the increase in luciferase activity was specific for E2 since progesterone or dexamethasone were ineffective in modifying luciferase activity through the TGFα 5′-flanking sequence. The results show that the TGFα 5′-flanking region contains a potential estrogen-responsive element(s) and that this region is upstream of the Sac-II restriction site.

AB - Expression of transforming growth factor α (TGFα) mRNA and protein can be stimulated by estrogens such as 17β-estradiol (E2) in estrogen-responsive rodent and human breast cancer cells. To ascertain if E2 can directly regulate TGFα expression through the 5′-flanking region of the human TGFα gene, E2- responsive MCF-7 or ZR-75-1 human breast cancer cells or E2-nonresponsive MDA-MB-231 breast cancer cells were transiently transfected with a plasmid containing an 1140-base pair (bp) Sac-I fragment of the TGFα 5′-flanking region ligated to the chloramphenicol acetyltransferase (CAT) gene. Cells that were transfected and subsequently treated with physiological concentrations of E2 (10−11-10−8 M) for 24 h exhibited a 2- to 10-fold increase in CAT activity. The E2 stimulation of CAT activity was dose-dependent with an increase first found at 10−10 M E2. The increase in CAT activity could be detected within 24-36 h after the addition of E2. There was no significant change in CAT activity in transiently transfected MDA-MB-231 cells as mediated through the TGFα 5′-flanking region after E2 treatment. MCF- 7 cells were also transiently transfected with different fragments of the TGFα 5′-flanking region ligated to the luciferase gene. In the absence of E2 treatment, no detectable luciferase activity was found. E2 was able to stimulate, in a dose-dependent manner, a 30- to 300-fold increase in luciferase activity in MCF-7 cells, which have been transfected with either a 2813-bp Pst-I, a 1565-bp Spe-I, a 1140-bp Sac-I, or a 370-bp Bam-HI TGFα-luciferase fragment. However, a loss in E2 responsiveness occurred when MCF-7 cells were transfected with a 77-bp Sac-II TGFα-luciferase plasmid. The induction of luciferase activity by E2 could be effectively blocked by simultaneous treatment of the cells with the antiestrogens tamoxifen or droloxifene. In addition, the increase in luciferase activity was specific for E2 since progesterone or dexamethasone were ineffective in modifying luciferase activity through the TGFα 5′-flanking sequence. The results show that the TGFα 5′-flanking region contains a potential estrogen-responsive element(s) and that this region is upstream of the Sac-II restriction site.

UR - http://www.scopus.com/inward/record.url?scp=0026378148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026378148&partnerID=8YFLogxK

U2 - 10.1210/mend-5-12-1955

DO - 10.1210/mend-5-12-1955

M3 - Article

C2 - 1791840

AN - SCOPUS:0026378148

VL - 5

SP - 1955

EP - 1963

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 12

ER -